Status:
COMPLETED
Preliminary Study of Endometrial Hyperplasia Groundwork for a Study to Define Precursors of Endometrial Cancer
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Endometrial Hyperplasia
Endometrial Cancer
Eligibility:
FEMALE
40-120 years
Brief Summary
This study, conducted jointly by the National Cancer Institute and the Kaiser Permanente Center for Health Research Northwest (KPCHRN) in Portland, Oregon, will lay the groundwork for a future study t...
Detailed Description
Three systems have been proposed to classify endometrial carcinoma precursors, but it is currently unclear which system best predicts cancer risk and is most reproducible. The optimal surrogate endpoi...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- All women who were members of the KPNW health plan between 1970 and 2003 who were at risk of developing endometrial carcinoma will be eligible.
- EXCLUSION CRITERIA:
- Women will be considered ineligible if they had substantial gaps in KPNW coverage during the years between the index biopsy and diagnosis date (cases) or censoring date (controls).
- NCI and KPNW will review otherwise eligible women who have coverage gaps to identify substantial gaps and determine eligibility on an individual basis.
Exclusion
Key Trial Info
Start Date :
November 25 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 6 2020
Estimated Enrollment :
745 Patients enrolled
Trial Details
Trial ID
NCT00339651
Start Date
November 25 2002
End Date
August 6 2020
Last Update
August 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Northwest
Hillsboro, Oregon, United States, 97124